{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T19:21:26Z","timestamp":1706988086735},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.amjopharm.2011.02.009","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T11:15:34Z","timestamp":1302866134000},"page":"194-198","source":"Crossref","is-referenced-by-count":7,"title":["Bisphosphonate-Related Subtrochanteric Femoral Fractures"],"prefix":"10.1016","volume":"9","author":[{"given":"Indunil","family":"Gunawardena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yama","family":"Rasekh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2011.02.009_bib1","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMe1003064","article-title":"Evolving data about subtrochanteric fractures and bisphosphonates","volume":"362","author":"Shane","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: Similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib3","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2009-1947","article-title":"Long-term use of bisphosphonates in osteoporosis","volume":"95","author":"Watts","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"10.1016\/j.amjopharm.2011.02.009_bib4","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.amjmed.2008.12.003","article-title":"Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis","volume":"122","author":"Bilezikian","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4158\/EP08306.ORR1","article-title":"Treatment of osteoporosis and prevention of new fractures: Role of intravenously administered bisphosphonates","volume":"15","author":"Cosman","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib6","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research","volume":"25","author":"Shane","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1302\/0301-620X.89B3.18146","article-title":"Subtrochanteric insufficiency fractures in patients on alendronate therapy: A caution","volume":"89","author":"Goh","year":"2007","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.injury.2007.08.036","article-title":"An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?","volume":"39","author":"Kwek","year":"2008","journal-title":"Injury"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","article-title":"Low-energy femoral shaft fractures associated with alendronate use","volume":"22","author":"Neviaser","year":"2008","journal-title":"J Orthop Trauma"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2265.2009.03581.x","article-title":"Unusual mid-shaft fractures during long-term bisphosphonate therapy","volume":"72","author":"Odvina","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib11","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1210\/jc.2007-2803","article-title":"Severely suppressed bone turnover and atypical skeletal fragility","volume":"93","author":"Visekruna","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib12","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/BF03346353","article-title":"Looking beyond low bone mineral density: Multiple insufficiency fractures in a woman with post-menopausal osteoporosis on alendronate therapy","volume":"30","author":"Lee","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib13","first-page":"485","article-title":"Sequential non-traumatic femoral shaft fractures in a patient on long-term alendronate","volume":"13","author":"Cheung","year":"2007","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00402-007-0373-0","article-title":"Bilateral femoral insufficiency fractures treated with inflatable intramedullary nails: A case report","volume":"127","author":"Demiralp","year":"2007","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib15","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1359\/jbmr.090408","article-title":"Bilateral fractures of the femur diaphysis in a patient with rheumatoid arthritis on long-term treatment with alendronate: Clues to the mechanism of increased bone fragility","volume":"24","author":"Somford","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0883-5403(97)90184-4","article-title":"Subtrochanteric stress fracture of the femur following total knee arthroplasty","volume":"12","author":"Kumm","year":"1997","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib17","first-page":"31","article-title":"Should bisphosphonates be continued indefinitely?","volume":"61","author":"Schneider","year":"2006","journal-title":"Geriatrics"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib18","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s11999-009-0725-x","article-title":"Case reports: Two femoral insufficiency fractures after long-term alendronate therapy","volume":"467","author":"Sayed-Noor","year":"2009","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00068-005-1421-5","article-title":"Bilateral middiaphyseal femoral stress fractures in the elderly","volume":"35","author":"Husada","year":"2005","journal-title":"Eur J Trauma"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib20","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: A potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib21","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1359\/JBMR.050309","article-title":"Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters","volume":"20","author":"Arlot","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11914-010-0007-2","article-title":"Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates","volume":"8","author":"Nieves","year":"2010","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib23","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1359\/jbmr.090408","article-title":"Bilateral fractures of the femur diaphysis in a patient with rheumatoid arthritis on long-term treatment with alendronate: Clues to the mechanism of increased bone fragility","volume":"24","author":"Somford","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjopharm.2011.02.009_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11420-008-9077-4","article-title":"Case report of spontaneous, nonspinal fractures in a multiple myeloma patient on long-term pamidronate and zoledronic acid","volume":"4","author":"Wernecke","year":"2008","journal-title":"HSS J"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594611000134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594611000134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T22:44:31Z","timestamp":1560120271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594611000134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1543594611000134"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2011.02.009","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}